Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.2M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
9.26M
-
Shares change
-
0
-
Total reported value, excl. options
-
$13.9M
-
Value change
-
-$57.2K
-
Put/Call ratio
-
0.01
-
Number of buys
-
3
-
Number of sells
-
-10
-
Price
-
$1.50
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q3 2023
18 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.26M shares
of 22.2M outstanding shares and own 41.77% of the company stock.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (4.56M shares), VANGUARD GROUP INC (4.19M shares), CITIGROUP INC (477K shares), Man Group plc (35.1K shares), Parallel Advisors, LLC (1K shares), GHP Investment Advisors, Inc. (200 shares), Connor, Clark & Lunn Investment Management Ltd. (0 shares), OCCUDO QUANTITATIVE STRATEGIES LP (0 shares), Soleus Capital Management, L.P. (0 shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.